Showing results (151-160 of 672) with videos related to
Sort By:
Pageof 68
Antimicrobial Resistance and Infection Control|August 25, 2024
Predicting early appropriate therapy for patients infected by carbapenem-resistant Gram-negative pathogens in intensive care units in ItalyMatteo Bassetti, Gianpaola Monti, Anne Santerre Henriksen, et al.Cureus|June 19, 2020
Pitfalls of Computed Tomography in the Coronavirus 2019 (COVID-19) Era: A New Perspective on Ground-Glass OpacitiesSara Mehrabi, Silvia Fontana, Francesca Mambrin, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|May 4, 2019
Early post-liver transplant surgical morbidity in HIV-infected recipients: risk factor for overall survival? A nationwide retrospective studyUmberto Baccarani, Riccardo Pravisani, Miriam Isola, et al.Expert Opinion on Investigational Drugs|April 4, 2020
Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant <i>Staphylococcus aureus</i>: advances in phase I and II trialsMatteo Bassetti, Filippo Del Puente, Laura Magnasco, et al.International Ophthalmology|September 18, 2020
Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreakMassimo Nicolò, Lorenzo Ferro Desideri, Matteo Bassetti, et al.Journal of Global Antimicrobial Resistance|May 19, 2018
Is meropenem MIC increase against KPC-producing Klebsiella pneumoniae correlated with increased resistance rates against other antimicrobials with Gram-negative activity?Piergiorgio Cojutti, Assunta Sartor, Matteo Bassetti, et al.BMC Infectious Diseases|August 8, 2012
Does the adoption of EUCAST susceptibility breakpoints affect the selection of antimicrobials to treat acute community-acquired respiratory tract infections?Anna Marchese, Susanna Esposito, Ramona Barbieri, et al.Current Opinion in Infectious Diseases|February 19, 2020
Role of new antibiotics in the treatment of acute bacterial skin and skin-structure infectionsMatteo Bassetti, Laura Magnasco, Filippo Del Puente, et al.The Journal of Antimicrobial Chemotherapy|February 7, 2017
Ceftolozane/tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing urinary tract and intraabdominal infections in Europe: report from an antimicrobial surveillance programme (2012-15)Michael A Pfaller, Matteo Bassetti, Leonard R Duncan, et al.Expert Review of Anti-Infective Therapy|December 21, 2012
Epidemiology, diagnosis and treatment of Clostridium difficile infectionMatteo Bassetti, Giovanni Villa, Davide Pecori, et al.Pageof 68